Phraxis, Inc Seeking FDA 510(k) Clearance for InterGraft
What if a graft did not have to be sewn to native blood vessels, but could just open up veins for dialysis through a pinprick? That's what Phraxis has obtained Series D funding to do.
Read the full article » | Posted 05-12-2022
Related Articles
- VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
- Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
- eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025

